September 10, 2010
| Bio-IT World > IBM Looks to Build Up

IBM Looks to Build Up



Loading...

March 15, 2010 | IBM is intent on keeping Moore in business for the next 15 years. IBM researchers have partnered with two Swiss institutes to understand how the latest chip cooling techniques can support a 3D chip architecture. A vertical integration of chips could overcome current limitations of Moore's Law, ensuring that the number of transistors on a chip doubles every 18 months.

IBM, École Polytechnique Fédérale de Lausanne (EPFL) and the Swiss Federal Institute of Technology Zurich (ETH) signed a four-year collaborative project called CMOSAIC considering a 3D stack-architecture of multiple cores with a interconnect density from 100 to 10,000 connections per millimeter square. Researchers believe that these tiny connections and the use of hair-thin, liquid cooling microchannels measuring only 50 microns in diameter between the active chips are the missing links to achieving high-performance computing with future 3D chip stacks. IBM 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series!

Covering a broad array of topics within the life sciences and drug development industries, these complimentary 90-minute web symposiums provide an interactive platform to learn more about cutting-edge bio-IT topics through expert analysis and discussions.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
Recorded on August 3, 2010
Sponsored by: Pegasystems
Program Details | Access Recording 

Next Gen Data Management for Next Gen Life Sciences
September 8, 2010 | 1:00pm - 2:30pm EST
Sponsored by Quantum
Program Details | Register Today 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.